Mediator involvement in antigen-induced bronchospasm and microvascular leakage in the airways of ovalbumin sensitized Brown Norway rats

Abstract

1. To determine which mediators are involved in antigen-induced bronchospasm and microvascular leakage in the airways of ovalbumin sensitised Brown Norway rats we investigated the effect of a histamine H1 receptor antagonist, mepyramine, a 5-HT receptor antagonist, methysergide, and a cys-leukotriene-1 receptor antagonist, montelukast. 2. Ovalbumin at 1 mg kg-1 i.v. caused a significant increase in microvascular leakage in the airways and at 3 mg kg-1 i.v. caused a significant increase in airways resistance. 3. Histamine (1 mg kg-1 i.v.), 5-HT (0.1 mg kg-1 i.v.) and leukotriene D4 (LTD4, 50 μg kg-1 i.v.) caused a significant increase in microvascular leakage in the airways. 4. Mepyramine (1 mg kg-1 i.v.), methysergide (0.1 mg kg-1 i.v.), or montelukast (30 mg kg-1 i.v.) inhibited histamine, 5-HT or LTD4 -induced microvascular leakage respectively. 5. Methysergide (0.1 mg kg-1 i.v.) reduced ovalbumin-induced microvascular leakage in the trachea and at 0.3 mg kg-1 i.v. inhibited bronchospasm (38 and 58%, respectively). Montelukast (30 mg kg-1 p.o.) reduced ovalbumin-induced microvascular leakage in airway tissue to basal levels (78%) and inhibited ovalbumin-induced bronchospasm (50%). Mepyramine (3 mg kg-1 i.v.) had no effect on ovalbumin-induced leakage or bronchospasm. 6. A combination of all three compounds (mepyramine, methysergide and montelukast) reduced ovalbumin-induced microvascular leakage in airway tissue to basal levels (70-78%) and almost completely inhibited bronchospasm (92%). 7. Antigen-induced bronchospasm appears to equally involve the activation of 5-HT and cys-leukotriene-1 receptors whereas ovalbumin-induced microvascular leakage appears to be predominantly mediated by cys-leukotriene-1 receptors.